Prime Medicine (PRME) Revenue (2024 - 2026)

Prime Medicine (PRME) posted Revenue of $856000.0 for Q1 2026, up 2.15% on a QoQ basis from $838000.0 in Q4 2025, and down 41.13% year-over-year from $1.5 million in Q1 2025.

Prime Medicine (PRME) Revenue (2024 - 2026) Analysis & Trends

Prime Medicine's Revenue history runs 3 years deep, the most recent figure standing at $856000.0 for Q1 2026.

  • Quarterly Revenue fell 41.13% year-over-year to $856000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 4.89% YoY) and the FY2025 annual result came in at $4.6 million, up 55.28% from the prior year.
  • Revenue was $856000.0 for Q1 2026 at Prime Medicine, up from $838000.0 in the prior quarter.
  • Across five years, Revenue topped out at $2.2 million in Q4 2024 and bottomed at $209000.0 in Q3 2024.
  • A 3-year average of $1.1 million and a median of $985500.0 in 2025 frame the typical range for Revenue.
  • Peak annual rise in Revenue reached 486.12% in 2025, while the deepest fall reached 61.61% in 2025.
  • Prime Medicine's Revenue stood at $2.2 million in 2024, then sank by 61.61% to $838000.0 in 2025, then grew by 2.15% to $856000.0 in 2026.
  • Business Quant data shows PRME's Revenue at $856000.0 in Q1 2026, $838000.0 in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Prime Medicine 524.20 Mn 524.20 Mn - 856,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 856,000.00
Dec 31, 2025 838,000.00
Sep 30, 2025 1.23 Mn
Jun 30, 2025 1.12 Mn
Mar 31, 2025 1.45 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 209,000.00
Mar 31, 2024 591,000.00